Intel Chairman Omar Ishrak is planning to raise funds for a blank-check firm targeting deals in the health tech sector. Ishrak, who ran medical device firm Medtronic in the past, could file public registration papers with the US Securities and Exchange Commission soon. He is aiming to raise about $750 mn to $1 bn for the special purpose acquisition company or SPAC. Goldman Sachs Group is leading preparations for the IPO.